Betmiga Description

mirabegron

Manufacturer:

Distributor:

Zuellig

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

Each prolonged-release tablet contains 25 mg or 50 mg of mirabegron.
Excipients/Inactive Ingredients: Core tablet: Macrogols, Hydroxypropylcellulose, Butylhydroxytoluene, Magnesium stearate.
Film coating: Hypromellose, Macrogol, Iron oxide yellow, Iron oxide red*.
*For 25 mg strength only.

Asia's one-stop resource for medical news, clinical reference and education

Already a member? Sign in